サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1654302

全身イメージングの世界市場：市場規模・シェア・動向分析 (モダリティ別・用途別・最終用途別・地域別)、セグメント別予測 (2025年～2030年)

Whole Body Imaging Market Size, Share & Trends Analysis Report By Modality (CT, MRI, Nuclear Imaging), By Application (Oncology, Trauma And Emergency Care, Metastasis Detection), By End-use, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 200 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
全身イメージングの世界市場：市場規模・シェア・動向分析 (モダリティ別・用途別・最終用途別・地域別)、セグメント別予測 (2025年～2030年)
出版日: 2025年01月21日
発行: Grand View Research
ページ情報: 英文 200 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

全身イメージングの市場規模と動向：

世界の全身イメージングの市場規模は、2024年に295億8,000万米ドルとなり、2025年から2030年にかけてCAGR 5.94%で成長すると予測されています。

業界の成長を促進する主な要因には、診断精度と効率を高める急速な技術進歩が含まれます。予防検診に対する意識の高まりが、疾患の早期発見とモニタリングの需要を促進しています。さらに、がんや心血管疾患などの慢性疾患の有病率が高まっているため、高度な画像診断ソリューションが必要とされています。高齢化により様々な健康状態に陥りやすくなっていることも、タイムリーな診断と治療計画のために全身イメージング技術の採用が増加している要因となっています。

全身イメージングシステムは、1回の撮影で全身を包括的に見ることができるため、局所的なイメージング技術よりも効率的です。そのため、特定の部位をターゲットとした複数回のスキャンが不要となり、患者が繰り返しの処置にさらされることが減り、診断の遅れを最小限に抑えることができます。これらのシステムは、複数の臓器にまたがる転移を評価しなければならないがんのような全身疾患を特定するのに特に効果的です。また、隠れた病変や血管の状態、複数の器官に影響を及ぼす炎症性疾患など、局所的な検査では見落とされる可能性のある異常の検出にも役立ちます。

CTとMRIの技術的進歩は、撮像精度の向上、スキャン時間の短縮、患者の快適性の向上をもたらし、市場の成長にさらに寄与しています。高解像度画像、AIを活用した診断ツール、高度な3D画像処理機能などのイノベーションにより、複雑な病態の早期かつ正確な発見が可能になります。さらに、CTでは放射線量の低減、MRIでは造影効果の向上により、より安全で効果的な診断が可能となり、多様な医療用途での採用がさらに進んでいます。

がん、心血管疾患、糖尿病、神経疾患などの慢性疾患の有病率の増加も、全身イメージング産業の成長に寄与する主要因です。これらの疾患は、効果的な管理のために継続的なモニタリングや早期発見を必要とすることが多いため、CTやMRIのような高度なイメージング技術に対する需要が高まっています。全身イメージングは、慢性疾患の診断、病期分類、進行追跡において重要な役割を果たし、タイムリーな介入と患者の転帰改善を可能にするため、市場拡大に拍車をかけています。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 全身イメージング市場：変動要因・傾向・範囲

  • 市場連関の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因の分析
  • 全身イメージング市場：分析ツール
    • 業界分析：ポーターのファイブフォース分析
    • PESTEL分析

第4章 全身イメージング市場：モダリティ別の推定・動向分析

  • セグメントダッシュボード
  • 全身イメージング市場の変動分析
  • 全身イメージング市場：市場規模の予測と動向分析、モダリティ別 (2018～2030年)
  • コンピュータ断層撮影 (CT)
  • 磁気共鳴画像 (MRI)
  • 核イメージング
  • その他のモダリティ

第5章 全身イメージング市場：用途別の推定・動向分析

  • セグメントダッシュボード
  • 全身イメージング市場の変動分析
  • 全身イメージング市場：市場規模の予測と動向分析、用途別 (2018～2030年)
  • 腫瘍学
  • 外傷および救急医療
  • 転移検出
  • 全身健康診断

第6章 全身イメージング市場：最終用途別の推定・動向分析

  • セグメントダッシュボード
  • 全身イメージング市場の変動分析
  • 全身イメージング市場：市場規模の予測と動向分析、最終用途別 (2018～2030年)
  • 病院
  • 画像診断センター
  • その他のエンドユーザー

第7章 全身イメージング市場：地域別の推定と動向分析 (技術別・用途別・最終用途別)

  • 市場シェア：地域別 (2024年・2030年)
  • 市場ダッシュボード：地域別
  • 世界市場のスナップショット：地域別
  • 市場規模の予測と動向分析 (2018～2030年)
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 最新動向と影響分析：主な市場参入企業別
  • 企業/競合の分類
  • 主要企業の市場シェア分析 (2024年)
  • 企業ポジション分析
  • 企業分類 (新興企業、イノベーター、リーダー)
  • 企業プロファイル
    • GE HealthCare
    • Koninklijke Philips NV
    • Siemens Healthineers AG
    • Canon Medical Systems
    • Fujifilm Holdings Corporation
    • Mediso Ltd.
    • NeuroLogica (a subsidiary of Samsung Electronics)
    • United Imaging Healthcare
    • Shimadzu Corporation
図表

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3. North America whole body imaging market, By country, 2018 - 2030 (USD Million)
  • Table 4. North America whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 5. North America whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 6. North America whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 7. U.S. whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 8. U.S. whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 9. U.S. whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 10. Canada whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 11. Canada whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 12. Canada whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 13. Mexico whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 14. Mexico whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 15. Mexico whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 16. Europe whole body imaging market, By country, 2018 - 2030 (USD Million)
  • Table 17. Europe whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 18. Europe whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 19. Europe whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 20. UK whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 21. UK whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 22. UK whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 23. Germany whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 24. Germany whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 25. Germany whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 26. France whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 27. France whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 28. France whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 29. Italy whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 30. Italy whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 31. Italy whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 32. Denmark whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 33. Denmark whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 34. Denmark whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 35. Sweden whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 36. Sweden whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 37. Sweden whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 38. Norway whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 39. Norway whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 40. Norway whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 41. Asia Pacific whole body imaging market, By country, 2018 - 2030 (USD Million)
  • Table 42. Asia Pacific whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 43. Asia Pacific whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 44. Asia Pacific whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 45. Japan whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 46. Japan whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 47. Japan whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 48. China whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 49. China whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 50. China whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 51. India whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 52. India whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 53. India whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 54. Australia whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 55. Australia whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 56. Australia whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 57. South Korea whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 58. South Korea whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 59. South Korea whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 60. Thailand whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 61. Thailand whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 62. Thailand whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 63. Latin America whole body imaging market, By Country, 2018 - 2030 (USD Million)
  • Table 64. Latin America whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 65. Latin America whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 66. Latin America whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 67. Brazil whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 68. Brazil whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 69. Brazil whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 70. Argentina whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 71. Argentina whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 72. Argentina whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 73. Middle East & Africa whole body imaging market, By country, 2018 - 2030 (USD Million)
  • Table 74. Middle East & Africa whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 75. Middle East & Africa whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 76. Middle East & Africa whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 77. South Africa whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 78. South Africa whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 79. South Africa whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 80. Saudi Arabia whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 81. Saudi Arabia whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 82. Saudi Arabia whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 83. UAE whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 84. UAE whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 85. UAE whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 86. Kuwait whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 87. Kuwait whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 88. Kuwait whole body imaging market, By end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Whole body imaging market: market outlook
  • Fig. 14 Parent market outlook
  • Fig. 15 Related/ancillary market outlook
  • Fig. 16 Penetration and growth prospect mapping
  • Fig. 17 Industry value chain analysis
  • Fig. 18 Whole body imaging market driver impact
  • Fig. 19 Whole body imaging market restraint impact
  • Fig. 20 Whole body imaging market: Modality movement analysis
  • Fig. 21 Whole body imaging market: Modality outlook and key takeaways
  • Fig. 22 Computed tomography (CT) market estimates and forecast, 2018 - 2030
  • Fig. 23 Magnetic resonance imaging (MRI) market estimates and forecast, 2018 - 2030
  • Fig. 24 Nuclear imaging market estimates and forecast, 2018 - 2030
  • Fig. 25 Other modalities market estimates and forecast, 2018 - 2030
  • Fig. 26 Whole body imaging market: Application movement analysis
  • Fig. 27 Whole body imaging market: Application outlook and key takeaways
  • Fig. 28 Oncology market estimates and forecast, 2018 - 2030
  • Fig. 29 Trauma and emergency care market estimates and forecast, 2018 - 2030
  • Fig. 30 Metastasis detection market estimates and forecast, 2018 - 2030
  • Fig. 31 Full-body health screenings market estimates and forecast, 2018 - 2030
  • Fig. 32 Whole body imaging market: End use movement analysis
  • Fig. 33 Whole body imaging market: End use outlook and key takeaways
  • Fig. 34 Hospitals market estimates and forecast, 2018 - 2030
  • Fig. 35 Diagnostic imaging centers market estimates and forecast, 2018 - 2030
  • Fig. 36 Other end users market estimates and forecast, 2018 - 2030
  • Fig. 37 Global whole body imaging market: Regional movement analysis
  • Fig. 38 Global whole body imaging market: Regional outlook and key takeaways
  • Fig. 39 North America
  • Fig. 40 North America market estimates and forecasts, 2018 - 2030
  • Fig. 41 U.S.
  • Fig. 42 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 43 Canada
  • Fig. 44 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 45 Mexico
  • Fig. 46 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 47 Europe
  • Fig. 48 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 49 UK
  • Fig. 50 UK market estimates and forecasts, 2018 - 2030
  • Fig. 51 Germany
  • Fig. 52 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 53 France
  • Fig. 54 France market estimates and forecasts, 2018 - 2030
  • Fig. 55 Italy
  • Fig. 56 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 57 Spain
  • Fig. 58 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 59 Denmark
  • Fig. 60 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 61 Sweden
  • Fig. 62 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 63 Norway
  • Fig. 64 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 65 Asia Pacific
  • Fig. 66 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 67 China
  • Fig. 68 China market estimates and forecasts, 2018 - 2030
  • Fig. 69 Japan
  • Fig. 70 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 71 India
  • Fig. 72 India market estimates and forecasts, 2018 - 2030
  • Fig. 73 Thailand
  • Fig. 74 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 75 South Korea
  • Fig. 76 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 77 Australia
  • Fig. 78 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 79 Latin America
  • Fig. 80 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 81 Brazil
  • Fig. 82 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 83 Argentina
  • Fig. 84 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 85 Middle East and Africa
  • Fig. 86 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 87 South Africa
  • Fig. 88 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 89 Saudi Arabia
  • Fig. 90 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 91 UAE
  • Fig. 92 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 93 Kuwait
  • Fig. 94 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 95 Market share of key market players- Whole body imaging market
目次
Product Code: GVR-4-68040-502-8

Whole Body Imaging Market Size & Trends:

The global whole body imaging market size was valued at USD 29.58 billion in 2024 and is expected to grow at a CAGR of 5.94% from 2025 to 2030. Major factors driving the growth of the industry include rapid technological advancements that enhance diagnostic accuracy and efficiency. Rising awareness of preventive health checkups is fueling demand for early detection and monitoring of diseases. Additionally, the growing prevalence of chronic disorders such as cancer and cardiovascular diseases necessitates advanced imaging solutions. The aging population, being more prone to various health conditions, further contributes to the increased adoption of whole-body imaging technologies for timely diagnosis and treatment planning.

Whole-body imaging systems are more efficient than localized imaging techniques as they offer a comprehensive view of the entire body in a single session. This eliminates the need for multiple scans targeting specific regions, reducing patient exposure to repeated procedures and minimizing diagnostic delays. These systems are particularly effective in identifying systemic diseases such as cancer, where metastatic spread across multiple organs must be assessed. They also aid in detecting abnormalities that might be overlooked in regional scans, such as hidden lesions, vascular conditions, or inflammatory diseases affecting multiple systems.

Technological advancements in CT and MRI are further contributing to market growth as they enhance imaging precision, reduce scan times, and improve patient comfort. Innovations such as high-resolution imaging, AI-powered diagnostic tools, and advanced 3D imaging capabilities enable early and accurate detection of complex conditions. Additionally, reduced radiation doses in CT and improved contrast imaging in MRI ensure safer and more effective diagnostic procedures, further driving their adoption across diverse medical applications.

The increasing prevalence of chronic disorders, such as cancer, cardiovascular diseases, diabetes, and neurological conditions, is also a key factor contributing to the growth of the whole-body imaging industry. As these diseases often require ongoing monitoring and early detection for effective management, the demand for advanced imaging technologies like CT and MRI rises. Whole-body imaging plays a crucial role in diagnosing, staging, and tracking the progression of chronic disorders, allowing for timely interventions and improved patient outcomes, thereby fueling market expansion.

Global Whole Body Imaging Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global whole body imaging market report on the basis of modality, application, end-use, and region:

  • Modality Outlook (Revenue, USD Million, 2018 - 2030)
  • Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
  • Nuclear Imaging
  • Other Modalities
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Oncology
  • Trauma & Emergency Care
  • Metastasis Detection
  • Full-Body Health Screenings
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Diagnostic Imaging Centers
  • Other End Users
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Modality
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Modality outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Whole Body Imaging Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of chronic diseases requiring comprehensive diagnostic imaging
      • 3.2.1.2. Advancements in imaging technologies
      • 3.2.1.3. Growing demand for early and accurate disease diagnosis
      • 3.2.1.4. Expanding applications of whole-body imaging in oncology, cardiology, and neurology
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of advanced whole-body imaging systems
      • 3.2.2.2. Limited reimbursement and insurance coverage
      • 3.2.2.3. Limited availability of skilled healthcare professionals
  • 3.3. Whole Body Imaging Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Whole Body Imaging Market: Modality Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Whole Body Imaging Modality Market Movement Analysis
  • 4.3. Global Whole Body Imaging Market Size & Trend Analysis, by Modality, 2018 to 2030 (USD Million)
  • 4.4. Computed Tomography (CT)
    • 4.4.1. Computed tomography (CT) market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Magnetic Resonance Imaging (MRI)
    • 4.5.1. Magnetic resonance imaging (MRI) market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Nuclear Imaging
    • 4.6.1. Nuclear imaging market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Other Modalities
    • 4.7.1. Other modalities market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Whole Body Imaging Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Whole Body Imaging Application Market Movement Analysis
  • 5.3. Global Whole Body Imaging Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Oncology
    • 5.4.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Trauma and Emergency Care
    • 5.5.1. Trauma and emergency care market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Metastasis Detection
    • 5.6.1. Metastasis detection market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Full-Body Health Screenings
    • 5.7.1. Full-body health screenings market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Whole Body Imaging Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Whole Body Imaging End Use Market Movement Analysis
  • 6.3. Global Whole Body Imaging Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Diagnostic Imaging Centers
    • 6.5.1. Diagnostic imaging centers market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Other End Users
    • 6.6.1. Other End Users market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Whole Body Imaging Market: Regional Estimates & Trend Analysis By Technology, Application, End Use

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Competitive scenario
      • 7.5.1.3. Regulatory framework
      • 7.5.1.4. Reimbursement structure
      • 7.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory framework
      • 7.5.2.4. Reimbursement structure
      • 7.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory framework
      • 7.5.3.4. Reimbursement structure
      • 7.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Competitive scenario
      • 7.6.1.3. Regulatory framework
      • 7.6.1.4. Reimbursement structure
      • 7.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Reimbursement structure
      • 7.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. Reimbursement structure
      • 7.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Regulatory framework
      • 7.6.4.4. Reimbursement structure
      • 7.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. Regulatory framework
      • 7.6.5.4. Reimbursement structure
      • 7.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Regulatory framework
      • 7.6.6.4. Reimbursement structure
      • 7.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Competitive scenario
      • 7.6.7.3. Regulatory framework
      • 7.6.7.4. Reimbursement structure
      • 7.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Competitive scenario
      • 7.6.8.3. Regulatory framework
      • 7.6.8.4. Reimbursement structure
      • 7.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Competitive scenario
      • 7.7.1.3. Regulatory framework
      • 7.7.1.4. Reimbursement structure
      • 7.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Reimbursement structure
      • 7.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Reimbursement structure
      • 7.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Competitive scenario
      • 7.7.4.3. Regulatory framework
      • 7.7.4.4. Reimbursement structure
      • 7.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Competitive scenario
      • 7.7.5.3. Regulatory framework
      • 7.7.5.4. Reimbursement structure
      • 7.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Competitive scenario
      • 7.7.6.3. Regulatory framework
      • 7.7.6.4. Reimbursement structure
      • 7.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Competitive scenario
      • 7.8.1.3. Regulatory framework
      • 7.8.1.4. Reimbursement structure
      • 7.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory framework
      • 7.8.2.4. Reimbursement structure
      • 7.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Competitive scenario
      • 7.9.1.3. Regulatory framework
      • 7.9.1.4. Reimbursement structure
      • 7.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Competitive scenario
      • 7.9.2.3. Regulatory framework
      • 7.9.2.4. Reimbursement structure
      • 7.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Competitive scenario
      • 7.9.3.3. Regulatory framework
      • 7.9.3.4. Reimbursement structure
      • 7.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Competitive scenario
      • 7.9.4.3. Regulatory framework
      • 7.9.4.4. Reimbursement structure
      • 7.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Key company market share analysis, 2024
  • 8.4. Company Position Analysis
  • 8.5. Company Categorization (Emerging Players, Innovators and Leaders
  • 8.6. Company Profiles
    • 8.6.1. GE HealthCare
      • 8.6.1.1. Company overview
      • 8.6.1.2. Financial performance
      • 8.6.1.3. Product benchmarking
      • 8.6.1.4. Strategic initiatives
    • 8.6.2. Koninklijke Philips N.V.
      • 8.6.2.1. Company overview
      • 8.6.2.2. Financial performance
      • 8.6.2.3. Product benchmarking
      • 8.6.2.4. Strategic initiatives
    • 8.6.3. Siemens Healthineers AG
      • 8.6.3.1. Company overview
      • 8.6.3.2. Financial performance
      • 8.6.3.3. Product benchmarking
      • 8.6.3.4. Strategic initiatives
    • 8.6.4. Canon Medical Systems
      • 8.6.4.1. Company overview
      • 8.6.4.2. Financial performance
      • 8.6.4.3. Product benchmarking
      • 8.6.4.4. Strategic initiatives
    • 8.6.5. Fujifilm Holdings Corporation
      • 8.6.5.1. Company overview
      • 8.6.5.2. Financial performance
      • 8.6.5.3. Product benchmarking
      • 8.6.5.4. Strategic initiatives
    • 8.6.6. Mediso Ltd.
      • 8.6.6.1. Company overview
      • 8.6.6.2. Financial performance
      • 8.6.6.3. Product benchmarking
      • 8.6.6.4. Strategic initiatives
    • 8.6.7. NeuroLogica (a subsidiary of Samsung Electronics)
      • 8.6.7.1. Company overview
      • 8.6.7.2. Financial performance
      • 8.6.7.3. Product benchmarking
      • 8.6.7.4. Strategic initiatives
    • 8.6.8. United Imaging Healthcare
      • 8.6.8.1. Company overview
      • 8.6.8.2. Financial performance
      • 8.6.8.3. Product benchmarking
      • 8.6.8.4. Strategic initiatives
    • 8.6.9. Shimadzu Corporation
      • 8.6.9.1. Company overview
      • 8.6.9.2. Financial performance
      • 8.6.9.3. Product benchmarking
      • 8.6.9.4. Strategic initiatives